Come up with a name for your new list and we'll add to it:
Acetylon Pharmaceuticals raised a round of funding on May 11, 2011. Investors include
Leukemia & Lymphoma Society.
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…